PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
37 hedge funds and large institutions have $64.3M invested in PLx Pharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
1,050% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 2
450% more capital invested
Capital invested by funds: $11.7M → $64.3M (+$52.6M)
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
131% more funds holding
Funds holding: 16 → 37 (+21)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MSD Partners
New York
|
+$13.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.49M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.7M |
| 4 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$3.32M |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
+$2.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
-$166K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$151K |
| 3 |
HWA
Heritage Way Advisors
Rockford,
Illinois
|
-$56.4K |
| 4 |
BlackRock
New York
|
-$12K |
PLXP Hedge Fund Activity: Q1 2021 in Review
37 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q1 2021, worth a combined $64.3M — up 450% from $11.7M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new PLXP positions and 2 closed out — a net gain of 21 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was MSD Partners, opening a new position worth an estimated $13.7M. The largest seller was 683 Capital Management, exiting entirely with an estimated $166K sold.
- 37 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q1 2021, up from 16 in Q4 2020.
- Funds reported $64.3M of PLx Pharma Inc. Common Stock stock for Q1 2021, up 450% quarter-over-quarter.
- 23 funds opened new PLx Pharma Inc. Common Stock positions in Q1 2021 and 2 closed out, a net change of +21 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q1 2021 was MSD Partners, an estimated $13.7M added.
- The largest PLx Pharma Inc. Common Stock seller in Q1 2021 was 683 Capital Management, an estimated $166K sold.
Based on aggregated 13F filings for Q1 2021.